Search hospitals > South Carolina > Greenville
Prisma Health Cancer Institute - Butternut
Claim this profileGreenville, South Carolina 29605
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Leukemia
258 reported clinical trials
6 medical researchers
Summary
Prisma Health Cancer Institute - Butternut is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Prisma Health Cancer Institute - Butternut is involved with conducting 258 clinical trials across 453 conditions. There are 6 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Jeffrey W. Elder.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Ki Chung, MDPrisma Health Cancer Institute - Eastside5 years of reported clinical research
Expert in Cancer
Expert in Tumors
90 reported clinical trials
188 drugs studied
Aniket SahaBI-LO Charities Children's Cancer Center6 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
57 reported clinical trials
118 drugs studied
Jeffrey K. GiguerePrisma Health Cancer Institute - Faris7 years of reported clinical research
Studies Cancer
Studies Breast Cancer
26 reported clinical trials
64 drugs studied
Jeffrey W. ElderPrisma Health Cancer Institute - Faris12 years of reported clinical research
Studies Cancer
Studies Endometrioid Carcinoma
5 reported clinical trials
17 drugs studied
Clinical Trials running at Prisma Health Cancer Institute - Butternut
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Colon Cancer
Tumors
Bladder Cancer
Oropharyngeal Carcinoma
Pancreatic Neuroendocrine Tumors
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Prisma Health Cancer Institute - Butternut?
Prisma Health Cancer Institute - Butternut is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Prisma Health Cancer Institute - Butternut is involved with conducting 258 clinical trials across 453 conditions. There are 6 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Jeffrey W. Elder.